Impact BioMedical
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $7 | $0 | $0 | $0 |
Gross Profit | -4 | -283 | -279 | -281 |
EBITDA | -13,804 | -724 | -26,551 | 4,827 |
EBIT | -14,092 | -1,007 | -26,830 | 4,546 |
Net Income | -14,346 | -1,267 | -27,108 | 4,247 |
Net Change In Cash | 7 | 0 | 0 | 0 |
Free Cash Flow | -694 | -1,256 | -1,285 | |
Cash | 624 | 1,318 | 1,999 | 2,668 |
Basic Shares | 12,185 | 12,062 | 11,509 | 71,999 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,331 | $1,029 | $67 | $50 |
Gross Profit | 2,331 | 1,029 | 67 | |
EBITDA | -1,539 | -1,976 | -3,101 | -3,763 |
EBIT | -1,882 | -2,272 | -4,608 | -3,833 |
Net Income | -2,051 | -2,390 | -10,496 | -3,867 |
Net Change In Cash | 2,331 | 1,029 | 67 | 50 |
Free Cash Flow | -3,919 | -2,869 | -4,428 | -3,249 |
Cash | 1,999 | 1 | 726 | 142 |
Basic Shares | 232,502 | 191,298 | 185,636 | 125,189 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.17 |
2025-03-31 | -$0.10 |
2024-12-31 | -$2.35 |
2024-09-30 | $0.36 |
